Guolong Liu Selected Research

Maturation-Promoting Factor

1/2019

UBE2C overexpression in melanoma and its essential role in G2/M transition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guolong Liu Research Topics

Disease

12	Neoplasms (Cancer) 04/2021 - 09/2014
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2022 - 11/2019
3	Neoplasm Metastasis (Metastasis) 04/2021 - 11/2019
2	Abdominal Aortic Aneurysm 01/2022 - 01/2021
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 01/2020
2	Adenocarcinoma 01/2021 - 05/2019
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 09/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 09/2020
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2019
1	Neuroinflammatory Diseases 01/2022
1	Focal Cortical Dysplasia 01/2022
1	Rupture 01/2022
1	Epilepsy (Aura) 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Disease Progression 01/2021
1	Genomic Instability 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Inflammation (Inflammations) 03/2020
1	Infections 03/2020
1	Colitis 03/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 08/2019
1	Thrombosis (Thrombus) 08/2019
1	Stomach Neoplasms (Stomach Cancer) 11/2018
1	Esophageal Squamous Cell Carcinoma 04/2016
1	Prostatic Neoplasms (Prostate Cancer) 11/2014
1	Wounds and Injuries (Trauma) 12/2002
1	Hemorrhage 12/2002

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 04/2022 - 09/2014
4	Long Noncoding RNAIBA 01/2021 - 01/2021
3	Phosphopyruvate Hydratase (Enolase)IBA 04/2022 - 11/2019
3	Biological ProductsIBA 04/2022 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2019
2	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 09/2020
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2021
2	LigandsIBA 10/2020 - 01/2020
2	Phosphotransferases (Kinase)IBA 09/2020 - 09/2014
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2022
1	methylazoxymethanolIBA 01/2022
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2022
1	Pilocarpine (Ocusert)FDA LinkGeneric 01/2022
1	CateninsIBA 04/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	Lipocalin-2IBA 01/2021
1	N-methyladenosineIBA 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Biosimilar PharmaceuticalsIBA 01/2021
1	Monoclonal AntibodiesIBA 10/2020
1	B7-H1 AntigenIBA 09/2020
1	Immune Checkpoint InhibitorsIBA 09/2020
1	Uridine Diphosphate (UDP)IBA 03/2020
1	Dextran SulfateIBA 03/2020
1	DiazooxonorleucineIBA 03/2020
1	CC chemokine receptor 9IBA 01/2020
1	AldehydesIBA 01/2020
1	Maturation-Promoting FactorIBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	EnzymesIBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 11/2018
1	Complement System Proteins (Complement)IBA 04/2016
1	Interleukin-17 (Interleukin 17)IBA 04/2016
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2016
1	Immunoglobulin G (IgG)IBA 04/2016
1	Homeobox A10 ProteinsIBA 11/2014
1	TOR Serine-Threonine KinasesIBA 09/2014

Therapy/Procedure

6	Therapeutics 04/2021 - 11/2019
1	Endovascular Aneurysm Repair 01/2021
1	Stents 08/2019
1	Catheters 08/2019
1	Radiotherapy 05/2019
1	Immunotherapy 04/2016
1	Hepatectomy 12/2002
1	Operative Surgical Procedures 12/2002
1	Ligation 12/2002